Attitudes Toward COVID-19 Illness and COVID-19 Vaccination among Pregnant Women: A Cross-Sectional Multicenter Study during August-December 2020.

Autor:	Battarbee AN; Center for Women's Reproductive Health and Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Stockwell MS; Department of Pediatrics, Division of Child and Adolescent Health, Columbia University Irving Medical Center, New York, New York.; Department of Population and Family Health, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York.; Department of Obstetrics and Gynecology, New York-Presbyterian Hospital, New York, New York., Varner M; Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah., Newes-Adeyi G; Abt Associates, Bethesda, Maryland., Daugherty M; Centers for Disease Control and Prevention, Atlanta, Georgia., Gyamfi-Bannerman C; Department of Obstetrics and Gynecology, New York-Presbyterian Hospital, New York, New York.; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, New York., Tita AT; Center for Women's Reproductive Health and Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Vorwaller K; Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah., Vargas C; Department of Pediatrics, Division of Child and Adolescent Health, Columbia University Irving Medical Center, New York, New York., Subramaniam A; Center for Women's Reproductive Health and Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Reichle L; Abt Associates, Bethesda, Maryland., Galang RR; Centers for Disease Control and Prevention, Atlanta, Georgia., Powers E; Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah., Lucca-Susana M; Department of Obstetrics and Gynecology, New York-Presbyterian Hospital, New York, New York.; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, New York., Parks M; Center for Women's Reproductive Health and Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Chen TJ; Centers for Disease Control and Prevention, Atlanta, Georgia., Razzaghi H; Centers for Disease Control and Prevention, Atlanta, Georgia., Dawood FS; Centers for Disease Control and Prevention, Atlanta, Georgia.
Jazyk:	angličtina
Zdroj:	American journal of perinatology [Am J Perinatol] 2022 Jan; Vol. 39 (1), pp. 75-83. Date of Electronic Publication: 2021 Oct 01.
DOI:	10.1055/s-0041-1735878
Abstrakt:	Objective: The aim of the study was to evaluate pregnant women's attitudes toward COVID-19 illness and vaccination and identify factors associated with vaccine acceptability. Study Design: This was a cross-sectional survey among pregnant women enrolled in a prospective COVID-19 cohort study in Salt Lake City, UT, Birmingham, AL, and New York, NY, from August 9 to December 10, 2020. Women were eligible if they were 18 to 50 years old and <28 weeks of gestation. Upon enrollment, women completed surveys regarding concerns about COVID-19 illness and likelihood of getting COVID-19 vaccine if one were available during pregnancy. Vaccine acceptability was defined as a response of "very likely" or "somewhat likely" on a 4-point Likert scale. Factors associated with vaccine acceptability were assessed with multivariable logistic regression. Results: Of 939 pregnant women eligible for the main cohort study, 915 (97%) consented to participate. Among these 915 women, 39% self-identified as White, 23% Black, 33% Hispanic, and 4% Other. Sixty-two percent received an influenza vaccine last season. Seventy-two percent worried about getting sick with COVID-19. If they were to get sick, 92% worried about harm to their pregnancy and 80% about harm to themselves. Only 41% reported they would get a vaccine. Of women who were unlikely to get vaccinated, the most frequently cited concern was vaccine safety for their pregnancy (82%). Non-Hispanic Black and Hispanic women had lower odds of accepting a vaccine compared with non-Hispanic White women (adjusted odds ratios [aOR] 0.4, 95% CI 0.2-0.6 for both). Receipt of influenza vaccine during the previous season was associated with higher odds of vaccine acceptability (aOR 2.1, 95% CI 1.5-3.0). Conclusion: Although most pregnant women worried about COVID-19 illness, <50% were willing to get vaccinated during pregnancy. Racial and ethnic disparities in plans to accept COVID-19 vaccine highlight the need to prioritize strategies to address perceived barriers among groups at high risk for COVID-19. Key Points: · Less than half of pregnant patients stated they would get a COVID-19 vaccine.. · Protecting their baby was the most common reason for acceptance and refusal of the COVID-19 vaccine.. · Patients of minority race/ethnicity and those without prior influenza vaccination were less likely to accept the COVID-19 vaccine.. Competing Interests: C.G.B. has an unrestricted grant from SMFM/AMAG to study prematurity. The other authors report no conflict of interest. (Thieme. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu